Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Pro-inflammatory, cytotoxic CD4(+)CD28(-) T-cells with known defects in apoptosis have been investigated as markers of premature immuno-senescence in various immune-mediated diseases. In this study we evaluated the influence of polyclonal antilymphocyte globulins (ATG-Fresenius, ATG-F) on CD4(+)CD28(-) T-cells in vivo and in vitro. PRINCIPAL FINDINGS: Surface and intracellular three colour fluorescence activated cell sorting analyses of peripheral blood mononuclear cells from 16 consecutive transplant recipients and short-term cell lines were performed. In vivo, peripheral levels of CD3(+)CD4(+)CD28(-) T-cells decreased from 3.7 ± 7.1% before to 0 ± 0% six hours after ATG-F application (P = 0.043) in 5 ATG-F treated but not in 11 control patients (2.9 ± 2.9% vs. 3.9 ± 3.0%). In vitro, ATG-F induced apoptosis even in CD4(+)CD28(-) T-cells, which was 4.3-times higher than in CD4(+)CD28(+) T-cells. ATG-F evoked apoptosis was partially reversed by the broad-spectrum caspase inhibitor benzyloxycarbonyl (Cbz)-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk) and prednisolon-21-hydrogensuccinate. ATG-F triggered CD25 expression and production of pro-inflammatory cytokines, and induced down-regulation of the type 1 chemokine receptors CXCR-3, CCR-5, CX3CR-1 and the central memory adhesion molecule CD62L predominately in CD4(+)CD28(-) T-cells. CONCLUSION: In summary, in vivo depletion of peripheral CD3(+)CD4(+)CD28(-) T-cells by ATG-F in transplant recipients was paralleled in vitro by ATG-F induced apoptosis. CD25 expression and chemokine receptor down-regulation in CD4(+)CD28(-) T-cells only partly explain the underlying mechanism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J., & Abbas, A. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80566-x · Cited by 639 · cited 2×
“As IL-2 signalling has been shown to enhance susceptibility to Fas-receptor/FasL mediated apoptosis, we expected IL-2 inhibition to decrease the apoptosis-rate of CD4CD28 T-cells, but not to affect CD4CD28(2) T-cells [9,42].”
BackgroundMethodMechanisms of action of antithymocyte globulin: T-cell depletion and beyond
Mohty, M. (2007) · Leukemia · doi:10.1038/sj.leu.2404683 · Cited by 611 · cited 1×
“Apart from their pro-apoptotic effects on lymphocytes, ATGs are known to be immunomodulatory influencing leukocyte chemotaxis and trafficking [11,12].”
BackgroundMonoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation · doi:10.1161/01.cir.101.25.2883 · Cited by 552 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundSchmidt, D., Goronzy, J. J., & Weyand, C. M. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118638 · Cited by 482
Goronzy, J. J., Fulbright, J. W., Crowson, C. S., Poland, G. A., O'Fallon, W. M., & Weyand, C. M. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12182-12187.2001 · Cited by 402 · cited 1×
“petence [36].”
T-cell-mediated lysis of endothelial cells in acute coronary syndromes
Nakajima, T., Schulte, S., Warrington, K. J., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2002) · Circulation · doi:10.1161/hc0502.103348 · Cited by 356
Yen, J.-H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., & Goronzy, J. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1159 · Cited by 335 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundProtective Conditioning for Acute Graft-versus-Host Disease
Lowsky, R., Takahashi, T., Liu, Y. P., Dejbakhsh-Jones, S., Grumet, F. C., Shizuru, J. A., Laport, G. G., Stockerl-Goldstein, K. E., Johnston, L. J., Hoppe, R. T., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050642 · Cited by 331 · cited 1×
“Furthermore, ATGs trigger apoptosis in B-cell lineages, interfere with functional properties of dendritic cells and induce the expansion and activation of regulatory and natural killer T-cells [12–14].”
BackgroundExpansion of unusual CD4+ T cells in severe rheumatoid arthritis
Martens, P. B., Goronzy, J. J., Schaid, D., & Weyand, C. M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400615 · Cited by 290 · cited 1×
“Recently, a subgroup of pro-inflammatory T-cells has been identified in patients with various chronic inflammatory diseases [15–21] and allograft recipients [22,23].”
BackgroundCD4+CD28− T Lymphocytes Contribute to Early Atherosclerotic Damage in Rheumatoid Arthritis Patients
Gerli, R., Schillaci, G., Giordano, A., Bocci, E. B., Bistoni, O., Vaudo, G., Marchesi, S., Pirro, M., Ragni, F., Shoenfeld, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131450.66017.b3 · Cited by 254
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., McFarland, H. F., & Martinꝉ, R. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12516 · Cited by 243
Feng, X., Kajigaya, S., Solomou, E. E., Keyvanfar, K., Xu, X., Raghavachari, N., Munson, P. J., Herndon, T. M., Chen, J., & Young, N. S. (2008) · Blood · doi:10.1182/blood-2008-01-130146 · Cited by 241
Genestier, L., Fournel, S., Flacher, M., Assossou, O., Revillard, J.-P., & Bonnefoy-Berard, N. (1998) · Blood · doi:10.1182/blood.v91.7.2360 · Cited by 217 · cited 6×
“The used ATG-F concentrations correspond with the expected serum concentrations of rabbit ATG at 80 to 200 mg/ml [8,9].”
BackgroundMethodResultInfluentialMarsh, J., Schrezenmeier, H., Marin, P., Ilhan, O., Ljungman, P., McCann, S., Socie, G., Tichelli, A., Passweg, J., Hows, J., et al. (1999) · Blood · doi:10.1182/blood.v93.7.2191 · Cited by 211
CD4+CD28– costimulation-independent T cells in multiple sclerosis
Markovic‐Plese, S., Cortese, I. C. M., Wandinger, K., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112516 · Cited by 210
BONNEFOY-BÉRARD, N., VINCENT, C., & REVILLARD, J.-P. (1991) · TRANSPLANTATION · doi:10.1097/00007890-199103000-00024 · Cited by 201 · cited 1×
“antibodies to various lymphocyte surface antigens [5–7].”
Schirmer, M., Vallejo, A. N., Weyand, C. M., & Goronzy, J. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.1018 · Cited by 191
Self-citationVallejo, A. N., Nestel, A. R., Schirmer, M., Weyand, C. M., & Goronzy, J. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8119 · Cited by 182 · cited 1×
“T-cells are a marker for chronic inflammation, early aging”
BackgroundSelf-citationPrognostic markers of radiographic progression in early rheumatoid arthritis
Goronzy, J. J., Matteson, E. L., Fulbright, J. W., Warrington, K. J., Chang‐Miller, A., Hunder, G. G., Mason, T. G., Nelson, A. M., Valente, R. M., Crowson, C. S., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11445 · Cited by 170 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundClonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways
Vallejo, A. N., Schirmer, M., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6301 · Cited by 169 · cited 14×
“CD4CD28(2) T-cells are resistant against apoptotic stimuli and are suggested to perpetuate chronic inflammation [24,25].”
BackgroundInfluentialSelf-citationREBELLATO, L. M., GROSS, U., VERBANAC, K. M., & THOMAS, J. M. (1994) · Transplantation · doi:10.1097/00007890-199403150-00010 · Cited by 167 · cited 1×
“Functional antibodies of rabbit ATGs to leukocyte adhesion molecules and chemokine receptors impair responses to chemotactic signals and lymphocyte trafficking to sites of inflammation [7,11].”
BackgroundWarrington, K. J., Kent, P. D., Frye, R. L., Lymp, J. F., Kopecky, S. L., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1775 · Cited by 150 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundFunctional antibodies to leukocyte adhesion molecules in antithymocyte globulins1
Michallet, M., Préville, X., Flacher, M., Fournel, S., Genestier, L., & Revillard, J. (2003) · Transplantation · doi:10.1097/01.tp.0000053198.99206.e6 · Cited by 144 · cited 2×
“Apart from their pro-apoptotic effects on lymphocytes, ATGs are known to be immunomodulatory influencing leukocyte chemotaxis and trafficking [11,12].”
BackgroundModulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritis
Bryl, E., Vallejo, A. N., Matteson, E. L., Witkowski, J. M., Weyand, C. M., & Goronzy, J. J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21353 · Cited by 142 · cited 1×
“however, up to now, only 33–36% decrement of peripheral CD4CD28 T-cells was observed after treatment with the antitumor necrosis factor-a (TNF-a) antibody, infliximab [37–40].”
BackgroundMechanisms of immunosuppression induced by antithymocyte globulins and OKT3.
Bonnefoy, N., & Jp, R. (1996) · PubMed · Cited by 142
Moosig, F., Csernok, E., Wang, G., & Gross, W. L. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00695.x · Cited by 138 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundDuftner, C., Goldberger, C., Falkenbach, A., Würzner, R., Falkensammer, B., Pfeiffer, K. P., Maerker-Hermann, E., & Schirmer, M. (2003) · Arthritis Res Ther · doi:10.1186/ar793 · Cited by 103
Self-citationLamprecht, P. (2001) · Thorax · doi:10.1136/thorax.56.10.751 · Cited by 96 · cited 1×
“Clinically, these cells were associated with the severity of rheumatoid arthritis and rheumatoid arthritis-associated vasculitis [26–28], ankylosing spondylitis [18], Wegeners’ granulomatosis [20,21], contributed to plaque instability in patients with coronary artery disease [29,30], and were”
BackgroundBiological and immunological characterization of ATG and ALG
Raefsky, E., Gascon, P., Gratwohl, A. A., SPECK, B., & Young, N. S. (1986) · Blood · doi:10.1182/blood.v68.3.712.712 · Cited by 90
Elevated pro-inflammatory CD4 + CD28 − lymphocytes and stroke recurrence and death
Nadareishvili, Z., Li, H., Wright, V., Maric, D., Warach, S. J., Hallenbeck, J. M., Dambrosia, J., Barker, J. L., & Baird, A. E. (2004) · Neurology · doi:10.1212/01.wnl.0000142260.61443.7c · Cited by 90
High Prevalence of Circulating CD4+CD28−T-Cells in Patients With Small Abdominal Aortic Aneurysms
Duftner, C., Seiler, R., Klein-Weigel, P., Göbel, H., Goldberger, C., Ihling, C., Fraedrich, G., & Schirmer, M. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000167520.41436.c0 · Cited by 85
Self-citationMichallet, M., Saltel, F., Préville, X., Flacher, M., Revillard, J., & Genestier, L. (2003) · Blood · doi:10.1182/blood-2003-04-1075 · Cited by 72 · cited 3×
“(2) Concerning ATG-induced apoptosis of pre-activated lymphocytes by either Fas-receptor/FasL-dependent pathways [9,10], Figure 2.”
BackgroundHan, D., Xu, X., Baidal, D., Leith, J., Ricordi, C., Alejandro, R., & Kenyon, N. S. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2281 · Cited by 66 · cited 1×
“allograft deterioration and may be useful in predicting graft loss [33,34].”
BackgroundRizzello, V., Liuzzo, G., Brugaletta, S., Rebuzzi, A., Biasucci, L. M., & Crea, F. (2006) · Circulation · doi:10.1161/circulationaha.105.588533 · Cited by 59 · cited 1×
“however, up to now, only 33–36% decrement of peripheral CD4CD28 T-cells was observed after treatment with the antitumor necrosis factor-a (TNF-a) antibody, infliximab [37–40].”
BackgroundBrugaletta, S., Biasucci, L. M., Pinnelli, M., Biondi-Zoccai, G., Di Giannuario, G., Trotta, G., Liuzzo, G., & Crea, F. (2006) · Heart · doi:10.1136/hrt.2004.052282 · Cited by 59 · cited 1×
“an even lower reduction of the frequency of peripheral CD4CD28(2) T-cells by statins in unstable angina [41].”
BackgroundTissue trafficking patterns of effector memory CD4 T cells in rheumatoid arthritis.
Zhang, X., Nakajima, T., Goronzy, J. J., & Weyand, C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21482 · Cited by 56 · cited 1×
“Indeed CD4CD28(2) T-cells are unique to combine receptors of short-lived memory effector cells and longlived central memory cells enabling these cells to home to both, peripheral inflammatory lesions as well as organized lymphoid organs [44].”
BackgroundAyuk, F. A., Fang, L., Fehse, B., Zander, A. R., & Kröger, N. M. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.08.004 · Cited by 41 · cited 1×
“(1) Previous reports had shown that supramitogenic doses of ATGs led to apoptosis of peripheral blood lymphocytes from healthy donors and myeloma cells depending on caspases, particularly on Cathepsin B [10,43].”
BackgroundPenack, O., Fischer, L., Gentilini, C., Nogai, A., Muessig, A., Rieger, K., Ganepola, S., Thiel, E., & Uharek, L. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.05.001 · Cited by 38 · cited 1×
“on CD4CD28 T-cells [9,47,48].”
ATG induction therapy: long-term effects on Th1 but not on Th2 responses
Weimer, R., Staak, A., Süsal, C., Streller, S., Yildiz, S., Pelzl, S., Renner, F. C., Dietrich, H., Daniel, V., Rainer, L., et al. (2005) · Transplant International · doi:10.1111/j.1432-2277.2004.00047.x · Cited by 36 · cited 1×
“Our in vitro cytokine data for the CD4CD28 T-cells are in line with previous studies revealing an ATG-F promoted production of IFN-c and TNF-a with a shift toward a Th1 cytokine profile [45,46].”
ResultThymoglobulin: an immunologic overview
Mueller, T. F. (2003) · Current Opinion in Organ Transplantation · doi:10.1097/00075200-200312000-00008 · Cited by 34 · cited 2×
“Clinical indications for ATGs include not only prevention (induction therapy) or rescue treatment of acute rejection, conditioning for haematopoietic stem cell transplantation from unrelated HLA-matched or haploidentical donors, treatment of graft-versus-host-disease [1] and severe aplastic anaemia [2], but also a res…”
BackgroundCD28 Down-Regulation on CD4 T Cells Is a Marker for Graft Dysfunction in Lung Transplant Recipients
Studer, S. M., George, M. P., Zhu, X., Song, Y., Valentine, V. G., Stoner, M. W., Sethi, J. M., Steele, C. H., & Duncan, S. R. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-013oc · Cited by 30 · cited 1×
“function after kidney and lung transplantation [22,32].”
Terasako, K., Sato, K., Sato, M., Kimura, S., Nakasone, H., Okuda, S., Kako, S., Tanaka, Y., Yamazaki, R., Oshima, K., et al. (2010) · Hematology · doi:10.1179/102453309x12583347113852 · Cited by 29 · cited 1×
“on CD4CD28 T-cells [9,47,48].”
Pawlik, A., Ostanek, L., Brzosko, I., Brzosko, M., Masiuk, M., Machaliński, B., & Gawronska-Szklarz, B. (2003) · Rheumatology International · doi:10.1007/s00296-003-0374-4 · Cited by 28
The expansion of CD4+CD28− t cells in patients with chronic kidney graft rejection
Pawlik, A., Florczak, M., Masiuk, M., Dutkiewicz, E., Machaliński, B., Rozanski, J., Domański, L., & Gawronska-Szklarz, B. (2003) · Transplantation Proceedings · doi:10.1016/j.transproceed.2003.10.061 · Cited by 25
Use of Anti-thymocyte Globulin in the Management of Refractory Systemic Autoimmune Diseases
Tarkowski, A., Anderson-gäre, B., & Aurell, M. (1993) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749309095136 · Cited by 21 · cited 1×
“Clinical indications for ATGs include not only prevention (induction therapy) or rescue treatment of acute rejection, conditioning for haematopoietic stem cell transplantation from unrelated HLA-matched or haploidentical donors, treatment of graft-versus-host-disease [1] and severe aplastic anaemia [2], but also a res…”
BackgroundNeutrophil Transmigration in Renal Proximal Tubular LLC-PK1 Cells
Joannidis, M., Truebsbach, S., Bijuklic, K., Schratzberger, P., Dunzendorfer, S., Wintersteiger, S., Lhotta, K., Mayer, G. J., & Wiedermann, C. J. (2004) · Cellular Physiology and Biochemistry · doi:10.1159/000076931 · Cited by 18 · cited 1×
“Transmigration of lymphocytes was quantified as described previously with some modification [50].”
MethodSelf-citationMengel, M., Mueller, I., Behrend, M., von Wasielewski, R., Radermacher, J., Schwarz, A., Haller, H. G., & Kreipe, H. H. (2004) · Transplant International · doi:10.1007/s00147-004-0691-x · Cited by 18
Dubey, S., & Nityanand, S. (2003) · Annals of Hematology · doi:10.1007/s00277-003-0645-x · Cited by 17 · cited 1×
“The supramitogenic dosages of ATG-F with 300 mg/ml and 1000 mg/ ml were chosen, because induction of cytokine production are dose-dependent and doses as high as 1000 mg/ml stimulated TNFa production in a previous study using horse ATG [49].”
MethodMengel, M., Mueller, I., Behrend, M., et al. (2004) · Transplant International · doi:10.1111/j.1432-2277.2004.tb00446.x · Cited by 15 · cited 1×
“allograft deterioration and may be useful in predicting graft loss [33,34].”
BackgroundBeneficial effects of antithymocyte globulin in severe cases of progressive systemic sclerosis.
Tarkowski, A., & Lindgren, I. (1994) · PubMed · Cited by 9
Beiras-Fernández, A., Thein, E., Chappell, D., Schropp, A., & Hammer, C. (2004) · Transplant Immunology · doi:10.1016/j.trim.2004.01.002 · Cited by 6 · cited 1×
“T-cells are in line with previous studies revealing an ATG-F promoted production of IFN-γ and TNF-α with a shift toward a Th1 cytokine profile”
ResultThe increased number of CD4+CD28- T cells in patients after liver transplantation.
Pawlik, A., Florczak, M., Masiuk, M., Machaliński, B., Syczewska, M., Szych, Z., & Gawronska-Szklarz, B. (2003) · PubMed · Cited by 3
Cited by
Senescence of T Lymphocytes: Implications for Enhancing Human Immunity
Akbar, A. N., Henson, S. M., & Lanna, A. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.002 · Cited by 285
“peripheral blood CD3(+)CD4(+)CD28(-) T-cells in vivo [62], however the mechanism involved were not clarified nor were the long term effects of depleting these cells.”
BackgroundCholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
Halder, N., & Lal, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660342 · Cited by 180
The life (and death) of CD 4 + CD 28 null T cells in inflammatory diseases
Dumitriu, I. E. (2015) · Immunology · doi:10.1111/imm.12506 · Cited by 118
Broadley, I., Pera, A., Morrow, G., Davies, K. A., & Kern, F. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00195 · Cited by 103
“Moreover, it has been demonstrated in organ transplant recipients that treatment with polyclonal anti-thymocyte globulin preferentially triggers apoptosis in CD4+CD28− compared to CD4+CD28+ T cells (89).”
BackgroundThe Story of CD4+CD28−T Cells Revisited: Solved or Still Ongoing?
Maly, K., & Schirmer, M. (2015) · Journal of Immunology Research · doi:10.1155/2015/348746 · Cited by 74
Self-citation
Metadata
- Authors
- Duftner, C., Dejaco, C., Hengster, P., Bijuklic, K., Joannidis, M., Margreiter, R., & Schirmer, M.
- Affiliations
- Innsbruck Medical University (AT)
- University of Graz (AT)
- Corresponding author
- Schirmer, Michael
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-30
- Volume
- 7
- Issue
- 3
- Pages
- e33939
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3316508
- OpenAlex
- W2056247835
- Cited by
- 23
- References
- 51
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 1 · 2016: 2 · 2015: 3
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fresenius Medical Care North America
- Karl-Franzens-Universität Graz
- Medizinische Universität Graz
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- antilymphocyte globulin, CD4+CD28- T cells, apoptosis, immunosuppression, transplant recipients, CD25 expression, chemokine receptor down-regulation, CXCR3, CCR5, CX3CR1, L-selectin, inflammatory cytokines, caspase inhibition, prednisolone
- MeSH terms
- Adult, Antilymphocyte Serum, Enzyme Activation, Female, Humans, Immunologic Factors, Inflammation, Interleukin-2, Lymphocyte Depletion, Male, Middle Aged, Signal Transduction, CD4-Positive T-Lymphocytes, Down-Regulation, Cytokines, Organ Transplantation, Apoptosis, CD3 Complex, CD28 Antigens, Th1 Cells, fas Receptor, Receptors, Chemokine, Caspases, Young Adult, Transendothelial and Transepithelial Migration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.